Exploration of the inhibition action of TPGS on tumor cells and its combined use with chemotherapy drugs
AbstractD-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) is a commonly used nonionic surfactant used as a pharmaceutical carrier in different drug delivery systems. TPGS can reverse P-glycoprotein (P-gp)-mediated multidrug resistance (MDR) and also has anticancer activities. It suggests...
Main Authors: | Lan Tang, Kaijuan Huang, Wenhui Jiang, Lulu Fu, Ran Zhang, Liting Shen, Zhimin Ou, Ye Huang, Zhenhai Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/10717544.2023.2183830 |
Similar Items
-
Pharmaceutical Properties of Nanoparticulate Formulation Composed of TPGS and PLGA for Controlled Delivery of Anticancer Drug
by: Mu, L., et al.
Published: (2003) -
Formation, characterization, and analysis
of curcumin nanoformulation for evaluating
its in vitro cytotoxicity
by: Nilam Parmar, et al.
Published: (2023-09-01) -
Targeting Colorectal Cancer Cells with Niosomes Systems Loaded with Two Anticancer Drugs Models; Comparative In Vitro and Anticancer Studies
by: Shaymaa Wagdy El-Far, et al.
Published: (2022-06-01) -
Design and Development of D‒α‒Tocopheryl Polyethylene Glycol Succinate‒<i>block</i>‒Poly(ε-Caprolactone) (TPGS−<i>b</i>−PCL) Nanocarriers for Solubilization and Controlled Release of Paclitaxel
by: Osman Yusuf, et al.
Published: (2021-05-01) -
TPGS2000-DOX Prodrug Micelles for Improving Breast Cancer Therapy
by: Tang L, et al.
Published: (2021-12-01)